Keyphrases
Multi-Ethnic Study of Atherosclerosis
100%
Right Ventricular
45%
Right Ventricle
41%
Ventricular Structure
39%
Ventricular Function
39%
Cardiovascular Disease
24%
Right Ventricular Mass
21%
Cardiovascular Risk
20%
Left Ventricular Mass
20%
Type 1 Diabetes Mellitus (T1DM)
14%
Left Ventricular Function
13%
Cardiovascular Events
13%
Magnetic Resonance Imaging
12%
Left Ventricular Hypertrophy
11%
Right Ventricular Volume
11%
Lung
11%
Arrhythmogenic Right Ventricular Dysplasia
11%
Cardiac Magnetic Resonance Imaging (cMRI)
10%
Ventricular Morphology
10%
Race-ethnicity
9%
Hispanic
9%
Hazard Ratio
8%
Confidence Interval
8%
Emphysema
7%
Cardiac Magnetic Resonance
7%
Atrial Fibrillation
7%
Race Differences
7%
African American
7%
End-diastolic Volume
7%
Right Ventricular Ejection Fraction
6%
Incident Atrial Fibrillation
6%
White People
6%
Physical Activity
6%
Obesity
6%
Diabetes Complications
6%
Right Ventricular Hypertrophy
6%
Hemoglobin A1c (HbA1c)
6%
Stroke Volume
6%
Body Mass Index
6%
Right Ventricular End-diastolic Volume
6%
Multi-ethnic
5%
Sex Differences
5%
Overall Survival
5%
Incident Heart Failure
5%
Immune Checkpoint Blockade
5%
Imaging Results
5%
Disease Syndrome
5%
P-wave Indices
5%
Type I Diabetes
5%
Discharge Frequency
5%
Medicine and Dentistry
Atherosclerosis
83%
Right Ventricle
42%
Cardiovascular Disease
33%
Cardiac Magnetic Resonance Imaging
25%
Magnetic Resonance Imaging
18%
Cardiovascular Risk
17%
End-Diastolic Volume
14%
Ejection Fraction
13%
Left Ventricular Hypertrophy
11%
Lung
11%
Atrial Fibrillation
11%
Arrhythmogenic Right Ventricular Dysplasia
11%
Insulin Dependent Diabetes Mellitus
11%
Diseases
10%
Congestive Heart Failure
9%
Body Mass Index
8%
Electrocardiogram
8%
Prevalence
7%
Emphysema
7%
Electrocardiography
7%
Right Ventricular Hypertrophy
7%
Race Difference
6%
Sex Difference
6%
Stroke Volume
6%
Cardiovascular System
6%
Physical Activity
6%
Hemoglobin A1c
6%
Linear Regression Analysis
5%
Gelatinase B
5%
Prostate Specific Membrane Antigen
5%
Positron Emission Tomography
5%
Prostate Cancer
5%
Patient with Type 1 Diabetes
5%
Body Surface
5%
DNA Methylation
5%
Cardiovascular Imaging
5%
Overall Survival
5%
Clinical Decision Making
5%
Glucose Metabolism
5%
Diabetic Neuropathy
5%
Selective Serotonin Reuptake Inhibitor
5%
Dyspnea
5%
Immune Checkpoint Blockade
5%
Standardized Uptake Value
5%
High Density Lipoprotein Cholesterol
5%
Brain Natriuretic Peptide
5%
Non Small Cell Lung Cancer
5%
Amino Terminal Sequence
5%
P Wave
5%
Plasminogen Activator Inhibitor-1
5%
